-
公开(公告)号:US20230391724A1
公开(公告)日:2023-12-07
申请号:US18029842
申请日:2021-10-01
申请人: Azafaros B.V.
发明人: Robert Hett , Fritz Blatter , Jennifer Robin , Kyle Landskroner
IPC分类号: C07D211/46
CPC分类号: C07D211/46 , C07B2200/13
摘要: The present invention relates to a crystalline form of compound (I) and a method of making the crystalline form of compound (I). The invention also provides pharmaceutical compositions comprising the crystalline form of compound (I). Furthermore, the invention relates to methods of using this crystalline form of compound (I) as a medicament and in the treatment of a disease involving abnormal levels of glucosylceramide and/or higher levels of glycosphingolipids.
-
公开(公告)号:US20240287001A9
公开(公告)日:2024-08-29
申请号:US18029842
申请日:2021-10-01
申请人: Azafaros B.V.
发明人: Robert Hett , Fritz Blatter , Jennifer Robin , Kyle Landskroner
IPC分类号: C07D211/46
CPC分类号: C07D211/46 , C07B2200/13
摘要: The present invention relates to a crystalline form of compound (I) and a method of making the crystalline form of compound (I). The invention also provides pharmaceutical compositions comprising the crystalline form of compound (I). Furthermore, the invention relates to methods of using this crystalline form of compound (I) as a medicament and in the treatment of a disease involving abnormal levels of glucosylceramide and/or higher levels of glycosphingolipids.
-
公开(公告)号:US12116344B2
公开(公告)日:2024-10-15
申请号:US18029842
申请日:2021-10-01
申请人: Azafaros B.V.
发明人: Robert Hett , Fritz Blatter , Jennifer Robin , Kyle Landskroner
IPC分类号: C07D211/46
CPC分类号: C07D211/46 , C07B2200/13
摘要: The present invention relates to a crystalline form of compound (I) and a method of making the crystalline form of compound (I). The invention also provides pharmaceutical compositions comprising the crystalline form of compound (I). Furthermore, the invention relates to methods of using this crystalline form of compound (I) as a medicament and in the treatment of a disease involving abnormal levels of glucosylceramide and/or higher levels of glycosphingolipids.
-
-